Plasma Lipidomics Profiling to Identify the Biomarkers of Diagnosis and Radiotherapy Response for Advanced Non-Small-Cell Lung Cancer Patients

<div>Principal component analysis of lipids in healthy controls and NSCLC patients was performed by partial least squares discrimination analysis (PLS-DA) analysis. (a) Principal component analysis of lipid species and scatters. (b) The histography of five component distributions and percentages.</div>

Journal of Lipids

fig2

Figure 2

Figure 2: Plasma Lipidomics Profiling to Identify the Biomarkers of Diagnosis and Radiotherapy Response for Advanced Non-Small-Cell Lung Cancer Patients 

Figure 2 | Plasma Lipidomics Profiling to Identify the Biomarkers of Diagnosis and Radiotherapy Response for Advanced Non-Small-Cell Lung Cancer Patients 